This study will investigate whether retaining potassium in the body will lead to changes in blood pressure and changes in blood and urine samples.
The purpose is to measure the effect of amiloride and spironolactone on: 1. Renal function (GFR, u-AQP2, u-ENaCβ, u-cAMP, u-PGE2, CH20, FENa, FEK), 2. Pulsbewave velocity, augmentation index and central blood pressure, 3. Vasoactive hormones (PRC, AngII, Aldo, AVP, ANP, BNP and Endot), and 4. Ambulatory blood pressure
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
Medical Research
Holstebro, Denmark
Blood pressure
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
5mg twice daily
25mg twice daily